The three human D-type cyclins, cyclin D1, D2 and D3 share the ability to bind to and activate cdk4 and 6. MMTV-cyclin D1 transgenic mice develop mainly adenocarcinoma, while MMTV-cyclin D2 mice show a lack of alveologenesis during pregnancy and only develop carcinoma at low frequency. The effect of cyclin D3 overexpression in mammary glands remains hitherto unknown. We generated MMTV-cyclin D3 transgenic mice and report here that they develop exclusively squamous cell carcinoma. We show that although cyclin D3 transgene expression was detected early in puberty, postnatal development and mammary gland proliferation were normal in virgin animals. In contrast, multiparous mice develop multiple foci of abnormal growth that correspond to various stages of squamous metaplasia. Therefore, our results support a role for cyclin D3 in squamous differentiation. In addition, we found that p16 expression during involution is abolished, while p27 expression increased in MMTV-cyclin D3 mice, two modifications that have been reported in the other MMTV-D-type cyclin transgenic models. Our observations indicate that despite biochemical redundancy in vitro and in vivo, D-type cyclins promote distinct oncogenic pathways.
Introduction
The cyclin-dependent kinases (cdk) are a family of protein serine/threonine kinases, which control cell cycle progression through association with their regulatory subunits, known as cyclins. Cyclins are classified into a large number of subtypes including the D-, E-, A-and B-type cyclins. Humans encode three D-type cyclins, cyclin D1, cyclin D2 and cyclin D3. D-type cyclins associate with cdk4 and 6 to promote the phosphorylation of the retinoblastoma (Rb) protein (for a review see Classon and Harlow, 2002) . Rb forms a complex with the E2F family of transcription factors and this represses their activity. Hyperphosphorylation of Rb results in the release of E2F, which then activates transcription of genes required for DNA replication and entry into the S phase (Trimarchi and Lees, 2002) . One of the early targets of E2F-mediated transcription is cyclin E that, together with cdk2, acts to maintain Rb phosphorylation. Constitutive expression of all three Dtype cyclins in the appropriate cell lines leads to a shortening of the G1 phase (Musgrove et al., 1994) indicating that D-type cyclins are rate limiting for progression into the S phase. This observation indicates that all the three D-type cyclins have the potential to act as oncogenes by activating cdk4 and 6.
Cyclin-cdk complexes are themselves regulated by two families of cdk inhibitors including p27 of the p21 family, which inhibits cyclin E-cdk2 complexes (Toyashima and Hunter, 1994) , and p16 of the INK4 family, which inhibits cyclin D-cdk4/6 complexes (Serrano et al., 1993) . D-type cyclins have the ability to sequester p21 and p27 away from cyclin E-cdk2 complexes (Bouchard et al., 1999; Perez-Roger et al., 1999) . Therefore, the oncogenic potential of D-type cyclins relies not only on their ability to promote Rb phosphorylation but also on their ability to titrate p21 and p27 away from cyclin E-cdk2 complexes, leading to their activation.
In breast cancer, cyclin D1 accumulates to abnormal levels in 35% of cases. The particular importance of cyclin D1 in breast cancer is supported by the observation that MMTV-cyclin D1 transgenic mice develop adenocarcinoma with papillary and cribriform elements, and also adenocarcinoma with squamous differentiation (Wang et al., 1994) . Further, cyclin D1 knockout mice show a defect in mammary gland proliferation during pregnancy (Sicinski and Weinberg, 1997; Fantl et al., 1999) and cyclin D1 was shown recently to be essential for tumor formation in MMTVras and MMTV-erbB-2 transgenic models . Thus, cyclin D1 is essential for normal cellular proliferation in the mammary gland during pregnancy and its dysregulation can lead to cancer. More recently, a pulse of p16 expression during involution was found to be essential for growth arrest during mammary gland involution (Gadd et al., 2001) . This pulse of p16 expression was abolished in MMTV-cyclin D1 transgenic mice and therefore it was suggested that cyclin D1 may contribute to tumorigenesis by altering p16-induced arrest and promote the expansion of the stem cell population (Gadd et al., 2001) .
Unlike cyclin D1 knockout animals, mice lacking cyclin D2 do not show alterations in mammary gland development (Sicinski et al., 1996) , suggesting that cyclin D2 does not perform an essential function in this tissue. Further, cyclin D2 overexpression in mammary glands results in a defect in alveologenesis during pregnancy and only a low frequency of tumorigenesis (Kong et al., 2002) . The proliferative defect observed in MMTV-cyclin D2 mice correlated with an increase in p27 expression and a decrease in cyclin D1 levels (Kong et al., 2002) . This observation is consistent with the recent study indicating that 50% of human breast cancers are associated with silencing of the cyclin D2 promoter (Evron et al., 2001) . Therefore, unlike cyclin D1, cyclin D2 appears to have predominantly a negative role on the proliferation of mammary epithelial cells and its downregulation is associated with cancer progression.
Although cyclin D3 is the most widely expressed member of the D-type cyclin family (Bartkova et al., 1998) , that cyclin D3 has been found to be overexpressed in several cancer types (Bartkova et al., 1996) and its expression correlates with high-grade breast cancers (Wong et al., 2001) , it is also the least studied. These observations raise the possibility that like cyclin D1, cyclin D3 overexpression may also contribute to tumor progression. To investigate the role of cyclin D3 in breast cancer, we have established transgenic mice overexpressing cyclin D3 from the MMTV promoter. We found that MMTV-cyclin D3 mice develop carcinoma at a high frequency (73%), indicating the ability of cyclin D3 to act as an oncogene. We show that p16 and p27 expression is modulated in MMTV-cyclin D3 mice in a similar fashion to what has been observed in the other D-type cyclin MMTV transgenic models; however, MMTV-cyclin D3 animals developed exclusively squamous cell carcinoma (SCC). Our results indicate that despite some overlap in their biochemical functions, the overexpression of D-type cyclins in mammary glands promotes unique phenotypes. Our data support a role of cyclin D3 in differentiation and raises the possibility that cyclin D3 is an early marker of squamous differentiation.
Results

Generation of MMTV-cyclin D3 transgenic mice
A construct encoding mouse cyclin D3 cDNA under the control of the MMTV-LTR was microinjected into FVB/n fertilized mouse oocytes and two female transgenic founder mice, numbers 72 and 81, were identified by Southern analysis (data not shown). MMTV-cyclin D3-72 and MMTV-cyclin D3-81 appear to have integrated a similar copy number of the cyclin D3 transgene. Southern analysis of genomic DNA of pups from the F1 generation from both founders confirmed transmission of the transgene and positive males and females were crossed to expand each line. Females from both lines were tested for expression of cyclin D3 by Western analysis. We found that while cyclin D3 expression was only faintly detectable in the mammary gland of wild-type animals (Figure 1 ), cyclin D3 levels were massively elevated in MMTV-cyclin D3 animals ( Figure 1 ) and that in agreement with the transgene copy number, both transgenic lines expressed cyclin D3 to similar levels. Further, we found that cyclin D3 was overexpressed in virgin transgenic mice (V) compared to the endogenous levels and that cyclin D3 expression was further increased following pregnancy (P) (Figure 1 ). We did not detect expression of the transgene in the salivary glands or other tissues in which genes under the control of the MMTV-LTR have been reported to be weakly expressed. Moreover, no expression of the transgene was detected in the testis, thus no further analysis of MMTV-cyclin D3 transgenic males was pursued. These results indicate that MMTV-cyclin D3-72 and MMTVcyclin D3-81 lines overexpressed cyclin D3 in their mammary glands.
Cyclin D3 overexpression during postnatal development
To test whether cyclin D3 levels are regulated during the development or the proliferative phases of the mammary gland cycle, we first analysed cyclin D3 expression by Western blotting in wild-type FVB/n mice. During postnatal development, the growth of mammary ducts is characterized by the presence of terminal end buds (TEBs), which represent sites of duct elongation and branching. At around 9 weeks of age, ducts reach the edge of the mammary fat pad, TEBs disappear and proliferation ceases. In FVB/n mice, cyclin D3 was detected at 9 weeks of age but not at 3 weeks (Figure 2a) , the expression levels did not vary in older virgin mice and were not increased during pregnancy (Figure 2a) . In contrast to wild-type mice, MMTV-cyclin D3 mice showed elevated levels of cyclin D3 as early as 3 weeks of age and the level of expression was further increased following pregnancy ( Figure 2a ). The effect of cyclin D3 expression on postnatal development at weeks 3-6 and 9 was tested by wholemount analysis of the mammary gland. Three mice of each genotype were tested at each time point. No difference in the time required for mammary tissue to invade the mammary fat pad was observed, nor was there a difference in the number, size or branching of the ducts (Figure 2b ). This observation indicates that the presence of elevated levels of cyclin D3 does not affect cellular proliferation during the early stage of mammary gland development.
Cyclin D3 levels are downregulated during involution
Pregnancy promotes proliferation and branching of ductal epithelium, which is followed by lobuloalveolar proliferation and differentiation during lactation. Growth arrest characterizes the terminal differentiation during the early phase of involution, while tissue remodeling in the second half of involution results in a return to the near epithelial cellularity of a virgin mammary gland. We tested whether cyclin D3 levels are regulated during involution. Wild-type and MMTVcyclin D3 female mice were kept with their litter for a period of 7 days. No difference of the ability to nurse their pups was detected between wild-type and MMTVcyclin D3 mice. Following lactation, litters were separated from their mothers to induce involution and mammary glands harvested at various time points during involution to determine cyclin D3 levels by Western blotting. The only change in cyclin D3 expression that was detected occurred during the early phase of involution, where cyclin D3 protein decreased to undetectable levels and resumed to normal levels during the second phase of involution ( Figure 3a) . Our results suggest that the elimination of cyclin D3 may be required during the first phase of involution. were harvested at the age of 3 weeks (3w), or 9 weeks (9w) for analysis of expression during postnatal development (PND). Mammary glands from adult virgin mice (o) or mice that had two pregnancies (2) were isolated, proteins extracted and analyzed by immunoblotting blotting (IB) using anti-cyclin D3 antibody. (b) Mammary glands from wild-type or MMTV-cyclin D3 mice at 9 weeks of age were isolated and analysed by whole mount In contrast, cyclin D3 expression remained constitutive during involution in MMTV-cyclin D3 transgenic mice (Figure 3a) . We therefore tested the effect of maintaining constitutive expression of cyclin D3 throughout involution using MMTV-cyclin D3 transgenic mice. Histological analysis of mammary glands from MMTV-cyclin D3 transgenic mice showed a minor delay of less than 1 day in involution compared to wildtype mice (Figure 3b, compare days 3 and 4) . However, no increase in cellularity at the completion of involution (day 6) was observed between mammary glands from MMTV-cyclin D3 transgenic and wild-type mice (Figure 3b) . Further, cyclin D3 overexpression had no detectable effect on the rate of apoptosis during involution (data not shown). Therefore, our results indicate that despite the absence of cyclin D3 expression during the first phase of involution, constitutive expression of cyclin D3 does not severely affect involution.
The expression of p16 during involution is abolished in MMTV-cyclin D3 transgenic mice
In wild-type mice, p16 is upregulated during the early phase of involution (Gadd et al., 2001 ) and this pulse of p16 expression has been proposed to be required for cell cycle arrest during the first phase of involution (Gadd et al., 2001) . In agreement with this hypothesis, sustained expression of p16 in MMTV-p16 transgenic mice promotes cell cycle arrest and results in a marked loss of lobuloalveolar proliferation (Gadd et al., 2001) . We tested the effect of constitutive expression of cyclin D3 on p16 expression during involution. Litters from wild-type FVB/n and MMTV-cyclin D3 female mice were kept with their mothers to lactate for a period of 7 days. Following lactation, litters were removed to initiate involution of the mammary glands. In FVB/n mice, p16 protein was detected at day 2 of involution, but was not detectable during lactation or at other times during involution (Figure 4a ). This result was confirmed by immunohistochemistry using p16 antibodies on mammary gland tissue sections of wild-type mice at day 2 of involution ( Figure 4b ). In contrast, p16 was not detected at any time during lactation or involution in MMTV-cyclin D3 transgenic mice (Figure 4a and b) . Therefore, we conclude that constitutive expression of cyclin D3 abolishes the pulse of p16 expression during the early phase of involution.
Abnormal expression of p27 in MMTV-cyclin D3 transgenic mice
In addition to p16, the level of the cdk inhibitor p27 has also been implicated in mammary gland development Muraoka et al., 2001; Tong and Pollard, 2001) . We therefore analysed the mammary glands of wild-type and transgenic mice for expression of cyclin D3 and p27. In agreement with the level of cyclin D3 detected by Western blotting (Figure 2a ), in Figure 4 p16 is expressed during involution in wild-type mice but not in MMTV-cyclin D3 transgenic mice. (a) Mammary glands from wild-type (top panel) and transgenic mice lower panel) were harvested after 3 days of lactation or after 1,2 or 4 days of involution. Proteins were extracted and analysed by Western blotting using anti-p16 antibody. (b) Mammary glands from the same mice used for Western analysis in (a) were isolated, fixed and embedded in paraffin blocks for immunohistochemical analysis using p16 antibody. Photographs were taken at Â 10 magnification
MMTV-cyclin D3 mice develop SCC
A Pirkmaier et al wild-type mice at day 1 of involution, cyclin D3 expression was not detectable (Figure 5a ), while p27 was mainly cytoplasmic (Figure 5a ) and was not detectable by day 2 of involution (data not shown). As expected, mammary glands at day 1 of involution in MMTV-cyclin D3 transgenic mice showed strong nuclear cyclin D3 expression (Figure 5b ), but surprisingly, p27 levels were also very high, and in contrast to the wild-type mice, p27 was predominantly nuclear (Figure 5b ). The nuclear accumulation of p27 was observed throughout involution (day 8, Figure 5b ), but not during pregnancy, despite the elevated levels of cyclin D3 (data not shown). This observation suggests that in addition to cyclin D3 overexpression, passage through lactation is required for the accumulation of p27 in the nucleus.
Despite the alteration in the expression of p16 and p27 in MMTV-cyclin D3 mice, no detectable difference in the morphology of mammary glands between wild-type and transgenic animals was detected following one or two pregnancies. The first histological abnormality in MMTV-cyclin D3 mice was detected after multiple pregnancies. In multiparous transgenic females, nodules of abnormal proliferation were detected by wholemount analysis (Figure 6a ). Pathological analysis of these lesions indicated that they were SCCs at different stages of progression that are characterized by keratin deposit (Figure 6b and c) . Most tumors were small and detected in mice aged between 1 and 2 year by wholemount analysis at an average age of 18 month. A small number of mice develop palpable tumors at an average age of 14.2 months (Table 1 , 7/33) that were also confirmed to be SCC. Remarkably, despite the similarity between the biochemical functions of cyclin D1 and cyclin D3, no adenocarcinomas were found in MMTVcyclin D3 transgenic mice (Table 1 ). In agreement with the lack of cyclin D3 transgene expression in other tissues, no SCC was found in other organs in MMTVcyclin D3 transgenic animals. Macrometastases were also not observed in other organs, even in transgenic mice with large palpable tumors. The formation of SCC was strictly restricted to multiparous MMTV-cyclin D3 mice ( Table 1 epithelium into squamous epithelium. Therefore, our results indicated either that higher levels of expression of cyclin D3, or that passage through pregnancy and involution in addition to cyclin D3 overexpression is required for SCC formation.
Discussion
Recent evidence indicates that cyclin Dl, D2 and D3 are functionally redundant as proliferation of most tissues in 'single-cyclin' mice is intact (Ciemerych et al., 2002) . The defects observed in single-cyclin mice were found to be associated with the inability to upregulate the remaining cyclin in specific tissues (Ciemerych et al., 2002) . Therefore, this study suggests that under normal conditions, cyclin Dl, D2 and D3 are exchangeable. However, under the abnormal condition where D-type cyclins are overexpressed, the oncogenic potential of individual D-type cyclins remained unclear. Only cyclin Dl and cyclin D3 are overexpressed in breast cancer, MMTV-cyclin D1 transgenic mice develop adenocarcinoma (Wang et al., 1994) . We have established two independent lines of MMTV-cyclin D3 transgenic mice and shown that both lines express cyclin D3 at similar levels. Cyclin D3 was expressed early in postnatal development and in adult virgin animals, but levels increased during pregnancy and remained elevated throughout involution. Despite this elevated expression, MMTV-cyclin D3 transgenic mice did not develop adenocarcinoma although they did develop SCC. There- fore, although cyclin D1 and D3 share multiple biochemical functions, only overexpression of cyclin D1 promotes adenocarcinoma. Our result suggests that the oncogenic potential of cyclin D1 relies on functions that are unique to this cyclin. As cyclin D1 but not cyclin D3 is able to activate the transcriptional activity of the estrogen receptor (ER) independently of its binding to cdk4 (Neuman et al., 1997; Zwijsen et al., 1997 Zwijsen et al., , 1998 , such activity may contribute to the unique oncogenic potential of cyclin D1. The physiological role of the interaction between cyclin Dl and the ER remains controversial, as expression of cyclin E under the control of the cyclin D1 promoter rescues the mammary glands defects in cyclin D1 knockout mice (Geng et al., 1999) . As cyclin E is also unable to bind the ER, this observation indicates that under normal conditions, the interaction between cyclin D1 and the ER is not essential for mammary gland development. However, under the condition where cyclin D1 accumulates to abnormally elevated levels, such as in the MMTV-cyclin D1 transgenic mice or in 35% of breast cancers, the ability of cyclin D1 to activate the ER may be important. Our data support a role for such interaction in the oncogenic potential of cyclin D1, however, determining the incidence of adenocarcinoma in transgenic mice overexpressing a mutant of cyclin D1 unable to bind to the ER would be required to clarify this possibility. Further, we cannot exclude the possibility that other yet undefined functions of cyclin D1 may also contribute to its unique ability to induce the formation of adenocarcinomas.
We have shown that MMTV-cyclin D3 transgenic mice develop SCCs exclusively. MMTV-cyclin D1 transgenic mice also develop SCC in addition to adenocarcinoma (Wang et al., 1994) . Therefore, the formation of SCC is not unique to the accumulation of cyclin D3, although cyclin D3 may be more potent than cyclin D1 in this respect. We found that overexpression of cyclin D3 during involution correlates with the absence of p16 expression. Accumulation of cyclin D1 in MMTV-cyclin D1 mice also abolishes the expression of p16 during involution (Gadd et al., 2001) . This effect of cyclin D1 was proposed to contribute to the expansion of the stem cell population (Gadd et al., 2001) . As the anlagen of the mammary gland is of epidermal origin, stem cells of the mammary gland may retain the potential to differentiate into epidermis. The ability of both cyclin D1 and cyclin D3 to abolish p16 expression during involution may therefore not only affect the expansion of the stem cell population but also affect their fate and promotes squamous differentiation.
Activation of multiple components of the b-catenin pathway promotes squamous metaplasia (Miyoshi et al., 2002a, b) . Although our preliminary data indicate that the migration of b-catenin is affected in MMTV-cyclin D3 transgenic mice (our unpublished data), we did not find strong evidence for the activation of this pathway. Therefore, it remains unclear whether b-catenin signaling, or other signaling pathways are involved in the formation of SCC in MMTV-cyclin D3 transgenic mice. Some investigators have speculated that squamous differentiation of tumors in MMTV-driven transgenes may occur as the result of chronic presence of milk during the multiple rounds of pregnancy used to induce tumors in MMTV-driven transgenic experiments. Although we cannot rule out that this effect may contribute to the formation of SCC, the fact that squamous differentiation was observed only in MMTVcyclin D3 mice and not in wild-type mice that went through the same number of pregnancies indicates that chronic milk production alone is not sufficient to induce SCC. Therefore, our data clearly show that cyclin D3 induces SCC formation and therefore raises the possibility that cyclin D3 may be a useful marker of SCC formation in tissues such as the cervix where SCC is frequent. However, we found that cyclin D3 was not expressed in the SCC observed in MMTV-cyclin D3 mice, a result that may simply reflect that the MMTV-LTR is not active in squamous cells. This hypothesis is supported by the observation that b-catenin expression is not observed either in SCC of MMTV-b-catenin transgenic mice (Miyoshi et al., 2002b) . Therefore, cyclin D3 may be useful as an early marker. We are currently testing this possibility.
We found that the cdk inhibitor p27 accumulates during lactation in MMTV-cyclin D3 transgenic mice. Recently, MMTV-cyclin D2 mice have been reported to affect lobuloalveolar development and this effect correlated with an increase in p27 expression. We found no defect in lobuloalveolar development in MMTVcyclin D3 mice indicating that accumulation of p27 alone is not sufficient to affect this process. As p27 in complex with cyclin D3 has been reported to promote keratinocyte differentiation (Hauser et al., 1997) , it is possible that when expressed together with cyclin D3, p27 contributes to the effect on the differentiation program of mammary epithelial cells. Therefore, it appears that p27 accumulation leads to different effects depending on whether it is in complex with cyclin D2 or cyclin D3.
We have characterized the effect of the third member of the D-type cyclin on mammary gland development and tumorgenesis. Collectively with the analysis of MMTV-cyclin D1 (Wang et al., 1994) and cyclin D2 (Kong et al., 2002) transgenic models, our findings indicate nonoverlapping phenotypes between the three D-type cyclins. Although MMTV-cyclin D3 transgenic mice do not develop adenocarcinoma, this finding does not rule out the possibility that cyclin D3 may participate to the development of breast cancer in humans when expressed in the context of other mutations. In support for such an hypothesis, microarray analysis has revealed that cyclin D3 levels are elevated in a subset of breast tumors characterized by the accumulation of the F-box protein Skp2 (Signoretti et al., 2002) . Cyclin D3/Skp2 positive tumors were found to be ER and erb-B2 negative, therefore to correspond to an aggressive tumor type (Signoretti et al., 2002) . In agreement with this finding, cyclin D3 expression correlates with higher tumor grade (Wong et al., 2001) . Therefore, MMTV-cyclin D3 transgenic mice represent an important model to test the effect of cyclin D3 accumulation in combination with other oncogenes.
Materials and methods
Generation of MMTV-cyclin D3 transgenic mice
The cDNA of mouse cyclin D3 was cloned into the EcoR1 site of an expression plasmid containing the mouse mammary tumor virus long terminal repeat (MMTV-LTR) plus SV40 intron and polyadenylation signals (Huang et al., 1981) . The linearized MMTV-cyclin D3 plasmid containing plasmid sequences in addition to the MMTV-LTR cyclin D3 fragment was microinjected into FVB/n fertilized mouse oocytes and two transgenic founder mice were identified by Southern analysis of EcoR1 digest of tail genomic DNA.
Antibodies and Western analysis
Mammary glands were removed surgically and frozen in liquid nitrogen. For protein extraction, mammary glands were transformed into a powder and proteins extracted by addition of NP-40 lysis buffer (50 mm Tris pH 7.5, 250 mm NaCl, 5 mm EDTA 0.5% NP-40, 0.1 mm sodium fluoride, 0.2 mm sodium orthovanadate, 1 mm dithiothreitol) containing the protease inhibitors (1 mg/ml aprotinin, 1 mg/ml leupeptin, 1 mg/ml pepstatin, 100 mg/ml PMSF, 100 mg/ml TPCK). The lysates were sonicated briefly on ice and clarified by centrifugation at 13000 g for 20 min at 41C. The protein concentration of the supernatant was assayed using a BCA Kit (Pierce).
A 30 mg aliquot of each lysate was diluted in SDS-PAGE sample buffer, the proteins denatured for 5 min at 951C, then fractionated on a 12% polyacrylamide gel, transferred onto a nitrocellulose membrane and subjected to standard Western blotting analysis using the primary antibodies. For detection of cyclin D3 by immunoblotting, the rabbit polyclonal antibody C-16 (Santa Cruz) was used at a dilution of 1 : 100. p27 was detected using the rabbit antibody, N-20 (Santa Cruz) at a dilution of 1 : 100. p16 was detected using the rabbit polyclonal antibody M-156 from Santa Cruz at a dilution of 1 : 100. The bound primary antibodies were visualized using anti-mouse or anti-rabbit-conjugated horseradish peroxidase secondary antibodies (Amersham) at a dilution of 1 : 3000 and chemiluminescence (ECL Kit, Amersham).
Whole-mount analysis
Mammary epithelium was isolated from MMTV-cyclin D3 or nontransgenic littermates, spread onto glass slides and fixed in Carnoy's fixative (six parts 100% ethanol, three parts chloroform, one part glacial acetic acid) overnight. The glands were then transferred into 70% ethanol for 15 min at room temperature and gradually into sterile milli-Q water before incubation in Carmine aluminum stain overnight. Glands were stored in 70% ethanol in the dark at room temperature.
Histology and immunohistochemistry
Mammary epithelium was isolated from MMTV-cyclin D3 or nontransgenic littermates, fixed in 10% buffered formalin, dehydrated, embedded in paraffin and sectioned at 3.5 mm. For histology, sections were stained with hematoxylin and eaosin. For immunohistochemistry, a mouse polyclonal antibody against mouse cyclin D3 (Ab-2, Oncogene) was used at a dilution of 1 : 25. For p27 the goat antibody (C-19, Santa Cruz) and for p16 rabbit polyclonal (M-156, Santa Cruz) were used at a dilution of 1 : 250.
For immunohistochemical staining of p27 and p16, tissue sections were dewaxed and rehydrated in water. Antigen retrieval was performed in a Sharp Carousel (600 W) microwave oven by bringing sections to boil in 10 mm sodium citrate pH 6.0 and then incubating for 20 min on medium (50%) power. Endogenous peroxidase activity was blocked with 3% (v/v) hydrogen peroxide for 10 min. Anti-p27 and anti-p16 antibodies were incubated for 30 min at room temperature and detected with the LSAB þ kit peroxidase (DAKO, Ko690), with the link biotinylated anti-goat IgG (DAKO, EO466) for 1 h and streptavidin peroxidase for 15 min. Slides were developed with AEC (3-amino-9-ethyl-carbazole) chromogen (DAKO) for 15 min. Sections were then counterstained in hematoxylin for 5 sec and mounted with DPX.
For cyclin D3 detection, to avoid background staining with anti-mouse antibody, the mouse anti-cyclin D3 antibody was linked to streptavidin secondary antibody before being applied to the section for 1 h using the DAKO ARK kit. Negative control for staining with these antibodies was performed using IgG1 (DAKO).
